Fohlin, H. (2024) “Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up”, Acta Oncologica, 63(1), pp. 535–541. doi: 10.2340/1651-226X.2024.40493.